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Abstract. – OBJECTIVE: The pathophysio-
logical role of cystatin C in cardiometabolic dis-
orders is not completely explored in young pop-
ulation. On the other hand, together with the in-
crease in obesity, dyslipidemia and insulin re-
sistance (IR) are often observed even in young-
sters. The aim of the study was to investigate 
the relationship between cystatin C and tri-
glycerides-to-high-density lipoprotein choles-
terol ratio (TG/HDL-c), as an indicator of dys-
lipidemia and a surrogate marker of IR in the 
cohort of adolescent girls ages between 16-19 
years.
PATIENTS AND METHODS: A total of 99 girls 
were included in the study. Anthropometric and 
biochemical parameters were provided. Asso-
ciations of biochemical markers with TG/HDL-c 
ratio were tested using univariable and mul-
tivariable ordinal regression analysis for TG/
HDL-c ratio tertiles as dependent variable. 
RESULTS: In univariate analysis, cystatin C 
levels were significantly associated with TG/
HDL-c ratio (OR=1.813; 95% CI: 1.190-2.757, 
p=0.005). Furthermore, multivariate analysis re-
vealed that cystatin C was an independent pre-
dictor of TG/HDL-c ratio when body mass in-
dex and high sensitivity C-reactive protein (i.e., 
markers that were significantly correlated with 
TG/HDL-c ratio in Spearman’s correlation analy-
sis) were included in the Model. Adjusted odds 
for cystatin C (OR=1.621; 95% CI: 1.028-2.552, 
p=0.037) demonstrated that rise in cystatin C by 
0.1 mg/L increased the probability for higher TG/
HDL-c tertile group by 1.621 times. 
CONCLUSIONS: Serum cystatin C levels are 
associated with TG/HDL-c ratio in adolescent 
girls. Longitudinal studies are needed to con-
firm the causal relationship between cystatin C 
and TG/HDL-c ratio and to further explore its di-
agnostic and therapeutic potential in dyslipid-
emia and insulin resistance in young population.
Key Words:
Cystatin C, Cardiometabolic risk, Dyslipidemia, In-
flammation.
Introduction
Adolescence represents a very challenging pe-
riod of life since the transition to adulthood is 
accompanied with many changes. Sedentary life-
style, smoking, increased alcohol intake, changes 
in eating habits, consumption of fast food, weight 
gain etc. favor an increased risk for obesity-relat-
ed cardiometabolic disorders that often track into 
adulthood1.
Given the rapid increase in overweight/obesity 
in young population, it is of great importance 
to early recognize high-risk youngsters and to 
treat them promptly in order to avoid or postpone 
cardiometabolic complications late in life. In line 
with this, regular physical activity2 and healthy 
dietary pattern3 are of urgent need to be imple-
mented. In addition, a new look to some relatively 
old biomarkers might be beneficial in earlier di-
agnosis and treatment of those individuals.
It is well known that dyslipidemia high-
ly correlates with obesity-related disorders4-11. 
Decreased high-density lipoprotein cholesterol 
(HDL-c) and increased triglycerides (TG) repre-
sent the hallmarks of dyslipidemia and a typical 
finding in insulin resistant state12. Accordingly, 
increased TG/HDL-c ratio, as an indicator of 
dyslipidemia and a surrogate marker of insulin 
resistance (IR) was shown to be reliable indicator 
of high cardiometabolic risk13. The high ratio 
of these two lipid parameters was shown to be 
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an independent predictor of hypertension14 and 
major adverse cardiovascular outcomes in female 
population15. Additionally, TG/HDL-c ratio neg-
atively correlates with the circulating levels of 
small dense low-density lipoprotein cholesterol 
(LDL) particles, which are recognized as more 
atherogenic ones than larger LDL-particles16. 
Similarly, in children and adolescents the re-
liability of TG/HDL-c ratio in IR prediction was 
shown12,17. Furthermore, it was reported that this 
ratio reflects atherosclerotic disturbances better 
than TG and HDL-c, separately17 and might be 
reliable in screening for metabolic disturbances18.
On the other hand, although cystatin C has 
been widely used as a biomarker of renal function 
(i.e., even better than creatinine, since it is not 
influenced by muscle mass)19,20 it was shown to 
exert many other metabolic properties in the last 
decade21,22. Researches that described that adipo-
cytes, pre-adipocytes, macrophages and endothe-
lial cells represent significant source of high level 
of cystatin C in circulation have shed a light on 
some novel roles of this biomarker in cardiometa-
bolic disorders22. Not only that it was found to be 
increased in obesity22, but also in the majority of 
states closely related to obesity, such as metabolic 
syndrome23, type 2 diabetes mellitus21, coronary 
heart disease24.
However, the pathophysiological role of cys-
tatin C in cardiometabolic disorders is not com-
pletely explored in young population since dis-
cordant results are presented so far19,20,25. As well, 
studies that examined the relationship between 
cystatin C and TG/HDL-c ratio in adolescent 
population are scarce. Therefore, in order to ob-
tain deeper insight into the pathophysiological 
properties of cystatin C in dyslipidemia and IR, 
the objective of this study was to investigate its 
relationship with TG/HDL-c ratio in the cohort of 
adolescent girls ages between 16-19 years.
Patients and Methods
Study Population
This study included a cohort of 99 consecu-
tively recruited adolescent girls from the third 
and fourth grade of two secondary schools in 
Podgorica. Each girl filled in a questionnaire, an-
swering the questions about lifestyle habits (i.e., 
smoking, physical activity, alcohol use), medica-
tions use and illnesses.
Inclusion criteria were normal weight or over-
weight/obese otherwise healthy girls who volun-
tarily accepted participation in the study. Girls 
younger than 16 years and older than 19 years 
of age, girls with a history of alcohol use or 
any medications use, smoking, acute or chronic 
inflammatory disease or any other disease were 
excluded. 
Institutional Ethical Committee approved the 
study protocol and the research was conducted 
in line with principles of the Declaration of Hel-
sinki. Signed informed approval was provided 
by each girl, whereas for participants younger 
than 18 years of age parental written consent was 
obtained, also.
Anthropometric Measurements
Anthropometric parameters: waist circumfer-
ence (WC), body weight and body height were 
taken. The body mass index (BMI) was calculat-
ed, as previously described26. Girls were consid-
ered to be normal weight if presented with BMI 
<25 kg/m2, whereas those with BMI ≥25 kg/m2 
were regarded to be overweight/obese.
Biochemical Analyses
The blood samples were collected in the morn-
ing after an overnight fast of at least 8 hours26. 
Serum cystatin C and high sensitivity C-reactive 
protein (hsCRP) levels were determined nephe-
lometrically (Behring Nephelometer Analyzer, 
Marburg, Germany). Standardized procedures 
were used for determination of serum levels of 
total cholesterol (TC), LDL-c, HDL-c, TG, glu-
cose, total proteins and creatinine and were mea-
sured on automatic analyzer (Roche Cobas 400, 
Mannheim, Germany).
Statistical Analysis
After data distribution testing with Shap-
iro-Wilk test, results are expressed as median 
and the interquartile range: 25th percentile, 75th 
percentile. Comparisons among the TG/HDL-c 
tertiles groups were made by the Kruskal-Wallis 
test. Post hoc comparisons were performed by 
Mann-Whitney U test. Categorical data were 
presented as absolute frequencies and compared 
by Chi-square test for contingency tables. The 
correlation between TG/HDL-c and demographic 
and laboratory data was examined by Spearman’s 
correlation analysis and data were presented as 
coefficient correlation (ρ). Univariable and mul-
tivariable ordinal regression analysis was em-
ployed to examine possible association of TG/
HDL-c and cystatin C levels. TG/HDL-c levels 
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(dependent variable) were ranked according to 
tertile values. Variables which significantly cor-
related with TG/HDL-c were set as independent 
variables (predictors). Data from these analyses 
were given as the estimated odds ratio (95% Con-
fidence Interval). A level of p less than 0.05 was 
defined as statistically significant.
Results
Female adolescents from the third TG/HDL-c 
tertile group were heavier, had higher BMI and 
WC than those from the first tertile group (Table 
I). As expected, there were statistically signifi-
cant differences in HDL-c, LDL-c, TG and non-
HDL-c levels between TG/HDL-c tertile groups. 
TG and non-HDL-c were the highest in the third 
tertile group, but they were also higher in the 
second compared to first tertile group. The oppo-
site was obtained for HDL-c levels. HDL-c levels 
were the lowest in the third tertile group, but they 
were also lower in the second compared to first 
tertile group. Significantly higher LDL-c concen-
trations were in the second and in the third group 
than in the first one. HsCRP levels were higher in 
the third than in the first TG/HDL-c tertile group 
(Table I). 
Figure 1 demonstrated significant differences 
in cystatin C levels among TG/HDL-c tertile 
groups (p=0.014). The highest cystatin C was 
obtained in the third group compared to the two 
other groups. 
Table I. Basic demographic and laboratory data according to TG/HDL-c ratio tertiles.
 The first The second The third 
 TG/HDL-c  TG/HDL-c TG/HDL-c 
 ratio tertile ratio tertile ratio tertile p**
Adolescent girls No. 33 33 33 
Age, years 18 (17-19) 18 (17-19) 18 (17-19) 0.506
Weight, kg 65 (56-69) 70 (60-75) 72 (64-91)a* 0.009
Height, cm 167 (166-172) 168 (165-173) 169 (166-174) 0.692
BMI, kg/m2 21.8 (19.8-25.2) 23.2 (20.8-26.4) 26.1 (22.3-30.9)a* 0.007
WC, cm 79 (75-83) 86 (74-93) 90 (79-100)a* 0.003
Glucose, mmol/L 5.1 (5.0-5.2) 5.0 (4.7-5.2) 5.0 (4.8-5.5) 0.379
Total proteins, g/L 73.0 (70.5-75.0) 73.0 (70.5-74.5) 73 (69-74) 0.769
Creatinine, µmol/L 57 (47-63) 58 (49-62) 52 (45-60) 0.665
TC, mmol/L 3.93 (3.54-4.34) 4.20 (3.83-4.63) 4.19 (3.76-4.73) 0.235
HDL-c, mmol/L 1.75 (1.41-1.95) 1.46 (1.33-1.60)a* 1.17 (1.01-1.35)a†,b† < 0.001
LDL-c, mmol/L 2.05 (1.79-2.36) 2.27 (2.15-2.57)a# 2.48 (2.13-2.90)a* 0.008
TG, mmol/L 0.55 (0.44-0.64) 0.81 (0.69-0.90)a† 1.19 (0.96-1.39)a†,b† < 0.001
Non-HDL-c, mmol/L 2.16 (1.81-2.54) 2.58 (2.45-2.79)a* 3.05 (2.63-3.45)a†,b# < 0.001
TG/HDL-c ratio 0.33 (0.27-0.38) 0.53 (0.47-0.61)a† 0.88 (0.75-1.20)a†,b† < 0.001
hsCRP, mg/L 0.33 (0.30-0.65) 0.62 (0.30-1.55) 0.78 (0.53-2.00)a* 0.013
Data are presented as median (interquartile range) and compared by Kruskal-Wallis test with post hoc Mann-Whitney test. **p 
for Kruskal-Wallis test. asignificantly different from the first TG/HDL-c tertile group. bsignificantly different from the second 
TG/HDL-c tertile group. *p<0.01; #p<0.05; †p<0.001. BMI-Body mass index; WC-Waist circumference; TC-Total cholesterol; 
HDL-cholesterol-High-density lipoprotein cholesterol; LDL-cholesterol-Low-density lipoprotein cholesterol; TG-Triglycerides; 
hsCRP-High-sensitivity C-reactive protein.
Figure 1. Cys C levels in adolescents according to TG/
HDL-c ratio tertiles. Data are presented as median (inter-
quartile range) and compared by Kruskal-Wallis test with 
post hoc Mann-Whitney test. p=0.014 for Kruskal-Wallis test. 
Cystatin C values for the first TG/HDL-c ratio tertile group 
was Median: 0.67, Interquartile range: 0.63-0.72; for the sec-
ond group Median: 0.67, Interquartile range: 0.63-0.70 and for 
the third group Median: 0.73, Interquartile range: 0.66-0.79.
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Unequal distribution of normal weight and 
overweight/obese adolescent girls were evident 
between all the three TG/HDL-c tertile groups 
(p=0.012) (Figure 2). No significant differences 
in distribution of normal weight and overweight/
obese adolescent girls were seen between the 
first and the second TG/HDL-c tertile group 
(p=0.120) and between the second and the third 
group (p=0.138). However, significantly more 
overweight/obese adolescent girls than normal 
weight ones were found in the third than in the 
first tertile group (p=0.003).
Furthermore, when divided all girls into nor-
mal weight (i.e., with BMI <25 kg/m2, n=54) and 
overweight/obese group (i.e., with BMI ≥25 kg/
m2, n=45), the median (interquartile range) for se-
rum cystatin C levels were as follows: 0.66 (0.63-
0.72) vs. 0.71 (0.66-0.80), p=0.009, respectively 
(data not presented).
Spearman’s correlation analysis showed that 
weight, BMI, WC, LDL-c, TG, non-HDL-c, 
hsCRP and cystatin C correlated positively with 
TG/HDL-c ratio (Table II). Also, significant neg-
ative correlation was expected between HDL-c 
and TG/HDL-c ratio. 
Ordinal regression analysis was performed to 
analyse in depth association of cystatin C and 
TG/HDL-c ratio. In univariate analysis, cystatin 
C levels were significantly associated with TG/
HDL-c ratio (OR=1.813; 95% CI: 1.190-2.757, 
p=0.005). This result indicated that as cystatin 
C level increases by 0.1 mg/L, the probability of 
adolescents’ classification in higher tertile TG/
HDL-c ratio group raises 1.813 times. Further-
more, multivariate analysis revealed that cystatin 
C was an independent predictor of TG/HDL-c 
ratio when BMI and hsCRP (i.e., markers that 
were significantly correlated with TG/HDL-c 
ratio in Spearman’s correlation analysis) were 
included in the Model. Adjusted odds for cysta-
tin C (OR=1.621, 95% CI: 1.028-2.552, p=0.037) 
demonstrated that rise in cystatin C by 0.1 mg/L 
increased the probability for higher TG/HDL-c 
tertile group by 1.621 times.
Discussion
Our results demonstrate the association be-
tween cystatin C levels and TG/HDL-c ratio in 
the cohort of adolescent girls. To the best of our 
knowledge, this is the first study that observed 
the relationship of cystatin C with TG/HDL-c 
ratio in adolescent girls of narrow age range and 
one among the scarce ones generally in young 
population. Even more, this association remained 
significant when obesity (i.e., determined with 
BMI) and inflammation (i.e., determined with 
hsCRP) were included in the analysis. Thus, we 
assume that an early recognition of increased 
serum cystatin C levels in adolescence may help 
to detect the dysregulation of lipid metabolism, 
increased IR and concomitantly increased car-
diometabolic risk for future event late in life. 
This may also enable physicians to treat promptly 
those high risk young individuals. 
Figure 2. Absolute frequencies of normal weight vs. over-
weight/obese female adolescents in TG/HDL-c ratio tertile 
groups. p for Chi-square test for contingency tables is 0.012.
Table II. Correlation coefficients of TG/HDL-c ratio with 
tested markers.
 ρ p
Age, years -0.097 0.338
Weight, kg 0.287 0.004
Height, m 0.047 0.645
BMI, kg/m2 0.309 0.002
WC, cm 0.327 0.001
Glucose, mmol/L -0.030 0.762
Total proteins, g/L -0.096 0.350
Creatinine, µmol/L -0.125 0.238
TC, mmol/L 0.147 0.145
HDL-c, mmol/L -0.656 < 0.001
LDL-c, mmol/L 0.294 0.003
TG, mmol/L 0.888 < 0.001
Non-HDL-c, mmol/L 0.516 < 0.001
hsCRP, mg/L 0.339 0.001
Cystatin C, mg/L 0.252 0.012
Data age given as coefficients of correlation Rho (ρ). BMI-
Body mass index; WC-Waist circumference; TC-Total cho-
lesterol; HDL-cholesterol-High-density lipoprotein choles-
terol; LDL-cholesterol-Low-density lipoprotein cholesterol; 
TG-Triglycerides; hsCRP-High-sensitivity C-reactive pro-
tein.
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Although controversies exist in some studies27, 
the association between cystatin C and some of 
individual lipid parameters was shown in adult 
population21. 
Similarly, Önerli Salman et al20 also reported 
the positive association between cystatin C and 
TG, TC and LDL-c, but an inverse association 
with HDL-c in the cohort of children and ado-
lescents ages between 6-18 years old. However, 
studies have shown that TG/HDL-c ratio better 
indicates atherosclerotic disturbances than TG and 
HDL-c, alone17. In line with this, cystatin C was 
reported to be associated with atherogenic index of 
plasma (i.e., log TG/HDL-c ratio) in adults28.
Our results agree with Harada et al29 who report-
ed that subgroup of Japanese boys ages between 12 
and 15 years old, who had high serum cystatin C 
levels displayed also the highest TG/HDL-c ratio. 
However, in subgroup of girls of similar age this 
statistical difference was not reached. Furthermore, 
Medeiros et al30 reported the significant correlations 
between eGFR CysC (i.e., estimated glomerular 
filtration rate that used cystatin C levels in its equa-
tion) and TG, HDL-c and IR. However, the men-
tioned correlations were showed only in males, but 
not in females. The possible discordance in such 
findings might be related to a dissimilar age range 
of examined cohorts, variability in sample-size 
groups, as well as ethnic differences.
We have reported higher cystatin C levels in 
obese/overweight adolescent girls as compared 
with normal weight counterparts (data not pre-
sented) which is in line with our previous find-
ings of its higher level in adult female population 
in other obesity-related disorders, such as meta-
bolic syndrome23 and fatty liver disease26.
Indeed, increased adipose tissue (especially 
those in visceral compartment) may be one of 
the major culprits of increased oxidative stress 
and inflammation in obesity-related disorders31-34. 
Increased production of reactive oxygen species, 
with concomitant increase in pro-inflammatory 
cytokines secretion promotes IR state and dyslip-
idemia31. Knowing that cystatin C is secreted by 
all nucleated cells, but especially by adipocytes, 
macrophages and endothelial cells22, the observed 
higher levels of this inflammatory biomarker in 
obesity-related disorders are not a surprise. Ac-
cordingly, in a prospective Malm Diet and Cancer 
study, Magnusson et al35 explained that the as-
sociation between cystatin C levels and incident 
metabolic syndrome might be mediated by viscer-
al fat, given the fact that serum cystatin C levels 
independently correlated with abdominal obesity. 
On the contrary, in a study that encompassed 
young population20 there was no difference in 
serum cystatin C and creatinine levels between 
obese and normal weight participants. However, 
obese patients with metabolic syndrome dis-
played higher serum cystatin C levels than obese 
subjects without metabolic syndrome suggesting 
that higher cystatin C could be used as an earlier 
parameter than higher serum creatinine in the 
recognition of the adverse effects of dyslipid-
emia on renal function in young population with 
obesity.
This can be explained by several mechanisms. 
Accumulation of fat leads to hemodynamic 
changes (i.e., hyperfiltration, enhanced glomer-
ular permeability, glomerular hypertension) and 
promotes oxidative stress, inflammation, apop-
tosis and concomitantly the occurrence of renal 
scarring36. Parallelly with the reabsorption of 
cholesterol and fatty acids by tubular epithelial 
cells, tubulointerstitial inflammation stimulates 
the generation of foam cells and damage of 
glomerular capillary endothelial and mesangial 
cells. In addition, the deposition of lipoproteins 
in the mesangial cells may promote production of 
matrix and subsequent glomerulosclerosis20.
The strength of the current study lies in the 
fact that examined cohort comprised of girls 
with a narrow age range (i.e., between 16-19 
years old), and thus we eliminated hormonal 
variations during childhood which might affect 
IR and inflammation markers. Moreover, we 
excluded some other factors which might be 
source of bias such as comorbidities, smoking 
and medications use.
The cross-sectional nature of this study rep-
resents its limitation and does not allow us to 
confirm the causality between cystatin C and TG/
HDL-c ratio. Additionally, we were not able to 
explore the influence of sex hormones on serum 
cystatin C levels in this cohort of adolescent girls. 
This might add contribution to the elucidation of 
the other factors influencing cystatin C levels in 
adolescence. Furthermore, longitudinal studies 
comprising both sexes would be of benefit in 
better understanding the role of cystatin C in 
obesity-related disorders.
Conclusions
As far as we know, this is the first study that 
demonstrated the relationship of cystatin C with 
TG/HDL-c ratio in adolescent girls of narrow 
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age range and one among the rare ones generally 
in children and adolescents. The obtained results 
might suggest cystatin C as reliable biomarker of 
severity of dyslipidemia and insulin resistance in 
adolescent age, especially in those girls presented 
with obesity. Prospective studies are needed to 
further examine its causal effect on obesity-relat-
ed disorders in young population.
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